» Articles » PMID: 36539107

Tracking the Clonal Dynamics of SARS-CoV-2-specific T Cells in Children and Adults with Mild/asymptomatic COVID-19

Abstract

Children infected with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) develop less severe coronavirus disease 2019 (COVID-19) than adults. The mechanisms for the age-specific differences and the implications for infection-induced immunity are beginning to be uncovered. We show by longitudinal multimodal analysis that SARS-CoV-2 leaves a small footprint in the circulating T cell compartment in children with mild/asymptomatic COVID-19 compared to adult household contacts with the same disease severity who had more evidence of systemic T cell interferon activation, cytotoxicity and exhaustion. Children harbored diverse polyclonal SARS-CoV-2-specific naïve T cells whereas adults harbored clonally expanded SARS-CoV-2-specific memory T cells. A novel population of naïve interferon-activated T cells is expanded in acute COVID-19 and is recruited into the memory compartment during convalescence in adults but not children. This was associated with the development of robust CD4 memory T cell responses in adults but not children. These data suggest that rapid clearance of SARS-CoV-2 in children may compromise their cellular immunity and ability to resist reinfection.

Citing Articles

Elevated Soluble ACE2 Activity in Children and Adults After SARS-CoV-2 Exposure Irrespective of Laboratory-Confirmed Infection.

Stich M, Magalhaes V, Burger F, Garbade S, Jeltsch K, Mohr K J Med Virol. 2024; 96(12):e70098.

PMID: 39624009 PMC: 11612704. DOI: 10.1002/jmv.70098.


COVID-19 progression and convalescence in common variable immunodeficiency patients show dysregulated adaptive immune responses and persistent type I interferon and inflammasome activation.

Rodriguez-Ubreva J, Calafell-Segura J, Calvillo C, Keller B, Ciudad L, Handfield L Nat Commun. 2024; 15(1):10344.

PMID: 39609471 PMC: 11605083. DOI: 10.1038/s41467-024-54732-x.


Preservation of functionality, immunophenotype, and recovery of HIV RNA from PBMCs cryopreserved for more than 20 years.

Dyer W, Suzuki K, Levert A, Starr M, Lloyd A, Zaunders J Front Immunol. 2024; 15:1382711.

PMID: 39221258 PMC: 11361978. DOI: 10.3389/fimmu.2024.1382711.


Improvement of immune dysregulation in individuals with long COVID at 24-months following SARS-CoV-2 infection.

Phetsouphanh C, Jacka B, Ballouz S, Jackson K, Wilson D, Manandhar B Nat Commun. 2024; 15(1):3315.

PMID: 38632311 PMC: 11024141. DOI: 10.1038/s41467-024-47720-8.


Natural and hybrid immunity after SARS-CoV-2 infection in children and adolescents.

Rothoeft T, Maier C, Talarico A, Hoffmann A, Schlegtendal A, Lange B Infection. 2024; 52(4):1449-1458.

PMID: 38499828 PMC: 11288991. DOI: 10.1007/s15010-024-02225-w.


References
1.
Bert N, Tan A, Kunasegaran K, Tham C, Hafezi M, Chia A . SARS-CoV-2-specific T cell immunity in cases of COVID-19 and SARS, and uninfected controls. Nature. 2020; 584(7821):457-462. DOI: 10.1038/s41586-020-2550-z. View

2.
Hsu D, Zaunders J, Plit M, Leeman C, Ip S, Iampornsin T . A novel assay detecting recall response to Mycobacterium tuberculosis: Comparison with existing assays. Tuberculosis (Edinb). 2012; 92(4):321-7. DOI: 10.1016/j.tube.2012.03.008. View

3.
Kang H, Subramaniam M, Targ S, Nguyen M, Maliskova L, McCarthy E . Multiplexed droplet single-cell RNA-sequencing using natural genetic variation. Nat Biotechnol. 2017; 36(1):89-94. PMC: 5784859. DOI: 10.1038/nbt.4042. View

4.
Kim M, Salloum S, Wang J, Wong L, Regan J, Lefteri K . Type I, II, and III Interferon Signatures Correspond to Coronavirus Disease 2019 Severity. J Infect Dis. 2021; 224(5):777-782. PMC: 8244575. DOI: 10.1093/infdis/jiab288. View

5.
Siska P, Decking S, Babl N, Matos C, Bruss C, Singer K . Metabolic imbalance of T cells in COVID-19 is hallmarked by basigin and mitigated by dexamethasone. J Clin Invest. 2021; 131(22). PMC: 8592546. DOI: 10.1172/JCI148225. View